|
India News Releases
|
(India.CityRegions.Com, November 26, 2018 ) Global Cancer Drug Industry was valued at USD 73.40 Billion in the year 2017. Global Cancer Drug Industry is further estimated to grow at a CAGR of 7.98% from 2018 to 2025 to reach USD 135.71 Billion by the year 2025. North America region holds the highest Industry share in 2017 with APAC region is considered as the fastest growing Industry in the forecasted period. At a country level, the U.S is the biggest Industry in 2017 and it is projected to grow at a gradual pace in the coming years.
The major market players in Cancer Drug Industry are Roche Holdings Inc., Johnson & Johnson, Novartis AG, Celgene, Eli Lilly and Company, Pfizer, Celgene Corporation, Sanofi, Merck & Co., Amgen Inc. (Other 13 companies detailed information is provided in research report). Roche Diagnostics holds the substantial Industry share because of its better global presence both at production and at an operational level. Rising research and development expenses to cater changing demand of end users, similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.
Get Free Sample Report@ www.qurateresearch.com/report/sample/HnM/QBI-GRS-HnM-116231
SWOT Analysis of Cancer Drugs Industry Strength Growing incidence and pervasiveness of various types of cancer Academic alliances and partnerships
Weakness Side-effects of anti-cancer drug therapy The high cost of drug development and a threat of failure
Opportunity Scientific advancements in treatment methods Increasing focus on personalized Anti-cancer medicine
Threats Patent Cliff
The Immunotherapy segment in the global Cancer Drug Industry is expected to hold the highest Industry share during the forecast period. The growth can be attributed to growing areas within oncology R&D, high efficacy and fewer side effects and unique molecular level targeting. On the other hand, Blood Cancer by the application is expected to grow at the highest CAGR during the year 2018-2025. Majorly due to growing number of blood cancer patient and the high cost of drugs used for the treatment of blood cancer.
Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-GRS-HnM-116231
By Application Gastrointestinal cancer Blood cancer Prostate cancer Skin cancer Respiratory/lung cancer Breast cancer Other types of cancers
By Products & Services Immunotherapy (biologics therapy) Hormonal therapy Targeted therapy Chemotherapy Others
Purchase Report@ www.qurateresearch.com/report/buy/HnM/QBI-GRS-HnM-116231/
By Region North America USA Canada Europe Germany U.K. France Italy Rest of Europe APAC China India Japan Rest of Asia-Pacific RoW Latin America Middle East & Africa
Qurate Business Intelligence
Nehal Chinoy
+919881074592
nehal@qurateresearch.com
Source: EmailWire.Com
|
|
|
India RSS Feed Marketpalce
|
India News Headlines
Daily news from India: arts, business, culture, politics, science, technology & more.
Free Sales & Marketing Magazines
Get free publications about marketing, sales and customer relations management.
Submit RSS feed on India. Have your feed on news, products or services displayed under this marketpalce and have your feed on a full page updated daily.
|
|
India Business News by Major Cities
|
|
|
Listen to GroupWeb Radio
INDIA BUSINESS TV
|